News

San Jose, CA – SoundCure, Inc. announced today that Bill Perry has joined the Company as General Manager.  Mr. Perry brings extensive experience in venture capital-backed medical device growth companies.  His successes include multiple mergers, acquisitions and an IPO.  Perry has more than 20 years of experience in management, sales, marketing and business development, primarily in the medical device industry.

“We are thrilled to have someone of Bill’s caliber manage the SoundCure team,” noted Marc Eichenberger, COO of Allied Minds, the parent company of SoundCure.  “Bill is a seasoned executive in the medical device field with a broad range of operational and strategic experience from start-ups to growth companies.  He has a record of creating shareholder value through the creation of sound strategies and thoughtful execution. We look forward to having him lead our business.”

Before joining SoundCure, Perry was President of Prosurgics, a small scale surgical robotics company focused on laparoscopic surgery. Previously, he was Senior Vice President of Business Development, Marketing and Sales for Nanomix, Inc., a medical device company focused on diagnostics and monitoring applications.  Prior to that, Perry held the position of Vice President, Worldwide Marketing and International Sales at VNUS Medical Technologies, Inc.  Earlier, he served as Vice President at companies such as Symphonix Devices, an innovative hearing implant company.  Perry holds a B.S. from Georgetown University and a Masters in International Management (MBA) from the Thunderbird School of Global Management.

“Tinnitus is a profoundly disturbing medical condition to millions of sufferers, and for quite some time, there have not been a lot of new treatments developed to deal with this serious issue,” said Mr. Perry.  “I greatly look forward to working with the SoundCure team and Allied Minds to bring to market our proprietary, breakthrough therapy and provide a solution to this very under-served patient population.”

About SoundCure
SoundCure is focused on developing and commercializing a novel acoustic therapy for the treatment of tinnitus (ringing in the ear).  The company will partner with audiologists, MD’s and patient advocacy groups and leverage innovative web-based technologies to treat patients and provide tinnitus solutions. Tinnitus is a debilitating disease that affects an estimated 262 million people worldwide.  SoundCure was formed by Allied Minds, a capital investment firm, based on technology first pioneered by researchers at University of California, Irvine who discovered a relation between certain tonal algorithms and specific therapeutic effects.

About Allied Minds
Allied Minds is a U.S. capital investment firm with offices in Boston, Los Angeles and Washington, D.C.  With over $200M in assets, the Company creates startup businesses based on early-stage technology developed at renowned U.S. universities and national labs, and serves as a holding company that supports these businesses with capital, management and shared services. Allied Minds is the premier firm to utilize this novel and fully integrated approach to technology investing. The Company’s subsidiary investments span multiple business sectors and offer an attractive risk-return profile, a deliverable timeline and potential products that will be groundbreaking in their respective fields. These subsidiaries include AXI, BA Logix, Biotectix, Cephalogics, CryoXtract, GliaGen, Illumasonix, ProGDerm, Precision Biopsy, Purtein, RF Biocidics, SaltCheck, SiEnergy Systems, SoundCure and Spin Transfer Technologies. For more information, please visit www.alliedminds.com

For more information;
Bill Perry, General Manager
SoundCure Inc., an Allied Minds company
Tel: +1 (408) 938-5745
bill.perry@soundcure.com